88 results on '"Macovei L"'
Search Results
2. Cut-off values for usual biomarkers as predictive risk factors for intra-stent restenosis
- Author
-
Mitu, I., primary, Alexandrescu, D.-M., additional, Costache, I.-I., additional, Macovei, L., additional, Alexandrescu, A., additional, Onofrei, V., additional, and Mitu, O., additional
- Published
- 2021
- Full Text
- View/download PDF
3. A systematic review on the correlations between left atrial strain and cardiovascular outcomes in chronic kidney disease patients
- Author
-
Kanbay, Mehmet (ORCID 0000-0002-1297-0675 & YÖK ID 110580), Tanasa, A.; Burlacu, A.; Popa, C.; Brinza, C.; Macovei, L.; Crisan-Dabija, R.; Covic, A., School of Medicine, Kanbay, Mehmet (ORCID 0000-0002-1297-0675 & YÖK ID 110580), Tanasa, A.; Burlacu, A.; Popa, C.; Brinza, C.; Macovei, L.; Crisan-Dabija, R.; Covic, A., and School of Medicine
- Abstract
Left atrial strain (LASr) represents a relatively new but promising technique for left atrial and left ventricle function evaluation. LASr was strongly linked to myocardial fibrosis and endocardial thickness, suggesting the utility of LASr in subclinical cardiac dysfunction detection. As CKD negatively impacts cardiovascular risk and mortality, underlying structural and functional abnormalities of cardiac remodeling are widely investigated. LASr could be used in LV diastolic dysfunction grading with an excellent discriminatory power. Our objectives were to assess the impact and existing correlations between LASr and cardiovascular outcomes, as reported in clinical trials, including patients with CKD. We searched PubMed, Web of Science, Embase, and the Cochrane Central Register of Controlled Trials for full-text papers. As reported in clinical studies, LASr was associated with adverse cardiovascular outcomes, including cardiovascular death and major adverse cardiovascular events (HR 0.89, 95% CI, 0.84-0.93, p < 0.01), paroxysmal atrial fibrillation (OR 0.847, 95% CI, 0.760-0.944, p = 0.003), reduced exercise capacity (AUC 0.83, 95% CI, 0.78-0.88, p < 0.01), diastolic dysfunction (p < 0.05), and estimated pulmonary capillary wedge pressure (p < 0.001). Despite limitations attributed to LA deformation imaging (image quality, inter-observer variability, software necessity, learning curve), LASr constitutes a promising marker for cardiovascular events prediction and risk evaluation in patients with CKD., NA
- Published
- 2021
4. FRI0551 PERFORMANCE OF THE 2019 AMERICAN COLLEGE OF RHEUMATOLOGY/EUROPEAN LEAGUE AGAINST RHEUMATISM SYSTEMIC LUPUS ERYTHEMATOSUS CLASSIFICATION CRITERIA
- Author
-
Vrancianu, C., primary, Conea, I., additional, Boca, A., additional, Bolboceanu, M., additional, Draganesscu, C., additional, Sasu, M., additional, Ciofu, C., additional, Macovei, L., additional, Milicescu, M., additional, Bojinca, M., additional, Ancuta, I., additional, Mihai, C., additional, Stoica, V., additional, and Gheorghiu, A. M., additional
- Published
- 2020
- Full Text
- View/download PDF
5. Iatrogenic Acute Aortic Dissection Complicating Coronary Catheterization
- Author
-
Macovei Liviu, Adoamnei Marius, Dumitrescu Irina, Panţiru Raluca-Mihaela, Năstasă Dan, Sascău Radu Andy, and Stătescu Cristian
- Subjects
iatrogenic ,dissection ,percutaneous coronary intervention ,resolute integrity drug eluting stent ,disecţie ,intervenţie coronariană percutanată ,stent activ farmacologic resolute integrity ,Internal medicine ,RC31-1245 - Abstract
Coronary dissection extending to the ascending aorta is an uncommon complication of invasive coronary procedures which carries a life-threatening risk. The performance of percutaneous coronary intervention (PCI) at centers without emergency surgical instruments has increased awareness of potential complications. We report a case of iatrogenic aortocoronary dissection in a patient admitted with acute myocardial infarction (AMI) who was treated during angioplasty.
- Published
- 2023
- Full Text
- View/download PDF
6. FRI0104 Predictors for the response to anti-tnf therapy and the impact of smoking in rheumatoid arthritis- results on a group of patients in romania
- Author
-
Gavrila, B.I., primary, Ciofu, C.S., additional, Macovei, L., additional, Gheorghiu, A.M., additional, Sasu, M., additional, Mihai, C., additional, Stoica, V., additional, Ancuta, I., additional, and Bojinca, M., additional
- Published
- 2018
- Full Text
- View/download PDF
7. FRI0428 Mean number of capillaries is associated with disease activity at 6 months follow-up in systemic sclerosis patients
- Author
-
Gheorghiu, A.M., primary, Oneata, R., additional, Radu, A., additional, Briceag, A., additional, Draganescu, C., additional, Vranceanu, C., additional, Magda, S., additional, Constantinescu, T., additional, Soare, A., additional, Dobrota, R., additional, Ancuta, I., additional, Ciofu, C., additional, Macovei, L., additional, Milicescu, M., additional, Sasu, M., additional, Enuica, A., additional, Linte, O., additional, Stan, G., additional, Comanescu, B., additional, Necsoiu, T., additional, Bojinca, M., additional, Stoica, V., additional, and Mihai, C., additional
- Published
- 2018
- Full Text
- View/download PDF
8. Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study
- Author
-
Miller, PD, McClung, MR, Macovei, L, Stakkestad, JA, Luckey, M, Bonvoisin, B, Reginster, JY, Recker, RR, Hughes, C, Lewiecki, EM, Felsenberg, D, Delmas, PD, Kendler, DL, Bolognese, MA, Mairon, N, and Cooper, C
- Abstract
UNLABELLED: Once-monthly (50/50, 100, and 150 mg) and daily (2.5 mg; 3-year vertebral fracture risk reduction: 52%) oral ibandronate regimens were compared in 1609 women with postmenopausal osteoporosis. At least equivalent efficacy and similar safety and tolerability were shown after 1 year. INTRODUCTION: Suboptimal adherence to daily and weekly oral bisphosphonates can potentially compromise therapeutic outcomes in postmenopausal osteoporosis. Although yet to be prospectively shown in osteoporosis, evidence from randomized clinical trials in several other chronic conditions shows that reducing dosing frequency enhances therapeutic adherence. Ibandronate is a new and potent bisphosphonate with antifracture efficacy proven for daily administration and also intermittent administration with a dose-free interval of >2 months. This report presents comparative data on the efficacy and safety of monthly and daily oral ibandronate regimens. MATERIALS AND METHODS: MOBILE is a 2-year, randomized, double-blind, phase III, noninferiority trial. A total of 1609 women with postmenopausal osteoporosis were assigned to one of four oral ibandronate regimens: 2.5 mg daily, 50 mg/50 mg monthly (single doses, consecutive days), 100 mg monthly, or 150 mg monthly. RESULTS: After 1 year, lumbar spine BMD increased by 3.9%, 4.3%, 4.1%, and 4.9% in the 2.5, 50 /50, 100, and 150 mg arms, respectively. All monthly regimens were proven noninferior, and the 150 mg regimen superior, to the daily regimen. All monthly regimens produced similar hip BMD gains, which were larger than those with the daily regimen. All regimens similarly decreased serum levels of C-telopeptide, a biochemical marker of bone resorption. Compared with the daily regimen, a significantly larger proportion of women receiving the 100 and 150 mg monthly regimens achieved predefined threshold levels for percent change from baseline in lumbar spine (6%) or total hip BMD (3%). All regimens were similarly well tolerated. CONCLUSIONS: Monthly ibandronate is at least as effective and well tolerated as the currently approved daily ibandronate regimen in postmenopausal osteoporosis.
- Published
- 2016
9. FRI0368 Nailfold capillaroscopy changes reflect endothelial activation and injury in patients with systemic sclerosis
- Author
-
Gheorghiu, AM, primary, Sfrent-Cornateanu, R, additional, Marta, D, additional, Bojinca, M, additional, Magda, S, additional, Constantinescu, T, additional, Soare, A, additional, Dobrota, R, additional, Macovei, L, additional, Stoica, V, additional, Bara, C, additional, and Mihai, C, additional
- Published
- 2017
- Full Text
- View/download PDF
10. SAT0681 Risk of active tuberculosis in patients with inflammatory arthritis receiving tnf-inhibitors
- Author
-
Gheorghiu, AM, primary, Garaiman, A, additional, Radu, A, additional, Soare, A, additional, Aramă, V, additional, Bumbăcea, D, additional, Dobrotă, R, additional, Oneata, R, additional, Pintilie, S, additional, Milicescu, M, additional, Ancuta, I, additional, Martin, A, additional, Sasu, M, additional, Ciofu, C, additional, Macovei, L, additional, Stoica, V, additional, Bojinca, M, additional, and Mihai, C, additional
- Published
- 2017
- Full Text
- View/download PDF
11. THU0607 Risk factors for early retirement in systemic sclerosis
- Author
-
Gheorghiu, AM, primary, Vrancianu, C, additional, Draganescu, C, additional, Oneata, R, additional, Macovei, L, additional, Sasu, M, additional, Milicescu, M, additional, Olteanu, O, additional, Speriatu, M, additional, Bojincă, M, additional, Stoica, V, additional, and Mihai, C, additional
- Published
- 2017
- Full Text
- View/download PDF
12. SAT0211 Reliability, Validity, and Sensitivity to Change of The Duruoz Hand Index in Systemic Sclerosis
- Author
-
Gherghe, A.M., primary, Gyorfi, H., additional, Capota, R., additional, Matei, A., additional, Oneata, R., additional, Milicescu, M., additional, Macovei, L., additional, Sasu, M., additional, Bojinca, M., additional, Stoica, V., additional, and Mihai, C., additional
- Published
- 2016
- Full Text
- View/download PDF
13. Performance médiocre de trois questionnaires de repérage de la BPCO
- Author
-
Macovei, L., primary, Boudjemaa, A., additional, Ben Hassen, I., additional, Mangiapan, G., additional, Saakashvili, Z., additional, Jérome, S., additional, Samé, V., additional, Boyer, L., additional, Schlemmer, F., additional, Maitre, B., additional, and Housset, B., additional
- Published
- 2016
- Full Text
- View/download PDF
14. SLEEP QUALITY AND PAIN CHARACTERISTICS IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, AND OSTEOARTHRITIS.
- Author
-
Burlui, M. A., Macovei, L., Cardoneanu, A., Stincescu, D. M., Codrianu, A., Bratoiu, I., Richter, P., and Rezus, E.
- Published
- 2023
- Full Text
- View/download PDF
15. THU0331 Increased Incidence of Tuberculosis Among Systemic Lupus Erythematosus Patients – Should Tuberculosis Screening at Diagnosis be the Next Step?
- Author
-
Gherghe, A.M., primary, Matei, A., additional, Györfi, H., additional, Soare, A., additional, Dobrota, R., additional, Sasu, M., additional, Macovei, L., additional, Ancuta, I., additional, Ciofu, C., additional, Milicescu, M., additional, Bojinca, M., additional, Stoica, V., additional, and Mihai, C., additional
- Published
- 2015
- Full Text
- View/download PDF
16. SAT0330 Active Tuberculosis in Arthritis Patients Receiving TNF Inhibitors Despite Baseline Screening
- Author
-
Soare, A., primary, Gherghe, A.M., additional, Dobrota, R., additional, Pintilie, S., additional, Oneata, R., additional, Ancuta, I., additional, Milicescu, M., additional, Martin, A., additional, Sasu, M., additional, Ciofu, C., additional, Macovei, L., additional, Stoica, V., additional, Bojinca, M., additional, and Mihai, C., additional
- Published
- 2015
- Full Text
- View/download PDF
17. THU0413 Preventing Active Tuberculosis in Rheumatoid Arthritis Patients Receiving TNF Inhibitors: TB Screening at Baseline is not Enough
- Author
-
Soare, A., primary, Mihai, C., additional, Gherghe, A.M., additional, Dobrota, R., additional, Pintilie, S., additional, Milicescu, M., additional, Ancuta, I., additional, Martin, A., additional, Macovei, L., additional, Ciofu, C., additional, Sasu, M., additional, Stoica, V., additional, and Bojinca, M., additional
- Published
- 2014
- Full Text
- View/download PDF
18. A3.2 Five year survival rate and predictors of death and disease worsening in a single-center cohort of patients with systemic sclerosis
- Author
-
Soare, A, primary, Mihai, C, additional, Dobrotă, R, additional, Gherghe, AM, additional, Vancea, C, additional, Gorga, M, additional, Ioniţescu, R, additional, Jurcuţ, R, additional, Magda, Ş, additional, Constantinescu, T, additional, Sfrenţ-Cornăţeanu, R, additional, Ancuţa, I, additional, Sasu, M, additional, Milicescu, M, additional, Macovei, L, additional, Ciofu, C, additional, Martin, A, additional, Shorab, A, additional, Bojincă, M, additional, and Stoica, V, additional
- Published
- 2014
- Full Text
- View/download PDF
19. The evaluation of cardiovascular risk in young patients with acute myocardial infarction
- Author
-
Macovei, L., primary, Presura, R., additional, Salaru, Delia, additional, and Arsenescu Georgescu, Catalina, additional
- Published
- 2013
- Full Text
- View/download PDF
20. Complication with Vital Risk in Marfan Syndrome
- Author
-
Macovei, L, primary
- Published
- 2013
- Full Text
- View/download PDF
21. Particularities of Acute Myocardial Infarction in Young Adults
- Author
-
Anghel Larisa, Prisacariu Cristina, Sascău Radu, Macovei Liviu, Cristea Elena-Cătălina, Prisacariu Georgiana, and Stătescu Cristian
- Subjects
myocardial infarction ,young patients ,coronary heart disease ,prognosis ,mortality ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Coronary heart disease occurs more often in patients over the age of 45. However, recent data shows a growing incidence of coronary events in younger patients also. Young patients with acute myocardial infarction (AMI) represent a relatively small proportion of subjects suffering from an acute ischemic event. However, they represent a subset that is distinguished from elderly patients by a different profile of risk factors, often atypical clinical presentation, and different prognosis. The prevalence of risk factors such as smoking, dyslipidemia, and a family history of coronary events is higher in this group of patients compared to the general population with AMI. Because of an important negative impact on the patients’ psychology, impaired working abilities, and a high socioeconomical burden, myocardial infarction in young patients represents an important cardiovascular pathology. This manuscript aims to present the particularities of AMI occuring at a young age, in comparison with the rest of the population with AMI.
- Published
- 2019
- Full Text
- View/download PDF
22. A Rare Cause of Ventricular Fibrillation Confirmed by Speckle-Tracking Imaging
- Author
-
Anghel Larisa, Dabija Eduard, Macovei Liviu, Prisacariu Cristina, Ivan Mihaela Viviana, and Georgescu Cătălina Arsenescu
- Subjects
ventricular fibrillation ,electrocution ,skin injuries ,speckle tracking ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Introduction: Cardiac arrhythmias caused by electrical injuries are rare among emergency service admittances. We present a case of ventricular fibrillation (VF) with a rare etiology, confirmed by speckle-tracking imaging.
- Published
- 2017
- Full Text
- View/download PDF
23. Rheumatoid arthritis: travelling biological era a Romanian X-ray population.
- Author
-
Mogosan, Corina, Stoica, V., Mihai, Carmen, Macovei, L., Ancuta, I., Ciofu, Claudia, Stefanescu, Fulvia, Bojinca, M., Martin, A., Milicescu, Mihaela, Crisan, Viorica, Banciu, Mioara, and Suteanu, St.
- Subjects
RHEUMATOID arthritis ,HEALTH surveys ,CROSS-sectional method ,MEDICAL care ,SOCIAL factors ,SOCIAL influence ,PATIENTS - Abstract
Background: rheumatoid arthritis (RA) is associated with loss of overall functionality of the locomotion system and it is connected with substantial economic losses. Objective: to describe the clinical characteristics and healthcare resource utilization characteristics and to analyze the correlations in a cross-sectional sample of 206 patients in Romania. Method: RA cases have been enrolled from southern and western part of the country, covering a surface of 23 counties. Results: particularly in the literature data, Romanian RA patients become work disabled at 5.65 ± 5.99 years old after the diagnosis. At cohort level, retirement in the first year after RA diagnosis is of 22.9%. From those, 13% were treated with biologic DMARDs; those on non-biologic DMARDs were 28.6%. In oral therapy group the most prescribed drug is lefunomide (61.2%). RA has an important impact on pain, function and utility, influenced by social factors. Patients' follow up is often based on hospitalization. Conclusion: currently, when the clinician may choose for one certain therapy or another, the social influence is still overwhelming at all the evaluation levels in RA patients, as well as at economic impact. [ABSTRACT FROM AUTHOR]
- Published
- 2009
24. Ischaemic signification of R-wave amplitude raising during the effort tachicardia induced (Brody effect)
- Author
-
Macovei, L., Georgescu, G., Arsenescu, Catalina, Sasciu, R., and Macovei, Carmen
- Subjects
Coronary heart disease -- Diagnosis -- Physiological aspects ,Tachycardia -- Physiological aspects -- Diagnosis ,Health ,Diagnosis ,Physiological aspects - Abstract
Objectives: 1. Quantification of Brady effect (BE) and establishing of its clinic relevance (sensitivity and specificity) in myocardial ischaemia diagnosis. 2. Assessment of the influence which left ventricular (LV) systolic [...]
- Published
- 2002
25. The Manufacturing of Textile Products with Incorporated Electrodes
- Author
-
Curteza Antonela, Cretu Viorica, Macovei Laura, and Poboroniuc Marian
- Subjects
textile electrodes ,electro-conductive textiles ,functional electrical stimulation ,rehabilitation ,conductive knitted fabric ,wearable electronics ,Textile bleaching, dyeing, printing, etc. ,TP890-933 - Abstract
One of the main causes of disabling deficits is neurological affections. Many times, the evolution of the condition leads to a diminution of the patient’s life quality. Functional electrical stimulation (FES) is part of the neurological rehabilitation process that comprises all the actions one can take in order to increase a patient’s integration and autonomy degree from a social and financial point of view. FES is a method based on substituting the commands that are usually transmitted by the nervous system with an electric impulse. The use of such a method on different body areas required the development of some adequate devices, starting with the stimulator itself and finishing with the way in which the stimulus is conveyed to the effectors. Textile materials that incorporate sensors and, mainly, the clothing products that have such components in their structure, have a high applicability potential; they can be used for preventing illnesses and for the rehabilitation of seniors, of people who are confined to bed, sportsmen, people who suffer from long-term illnesses, disabled people, thus diminishing the time one spends in the hospital. A possible solution for manufacturing incorporated textile electrodes consists in the insertion of some electro-conductive yarns onto textile surfaces by using a variety of technologies. The project approaches the use of knitting, a widespread textile technology. The incorporated knitted electrodes were accomplished by applying the knitting technology on single circular small diameter machines. Thus, we were able to obtain a variety of knitted articles as two-dimensional or three-dimensional tubular knitted fabric. Their dimensions, structures, and parameters correspond to the typo-dimensions of the human body and to the purpose for which the clothing product was designed. The knitted versions were tested by using a Microstim2v2 (PW = 300 μs, 40 Hz) neurostimulator for which the current intensity was adjusted to approx. 30 mA.
- Published
- 2016
- Full Text
- View/download PDF
26. Designing Functional Clothes for Persons with Locomotor Disabilities
- Author
-
Curteza Antonela, Cretu Viorica, Macovei Laura, and Poboroniuc Marian
- Subjects
disabilities ,design ,integration ,functions ,sensations ,cool ,heating ,stitch ,Textile bleaching, dyeing, printing, etc. ,TP890-933 - Abstract
The life quality improvement issue is a problem of national and international interest. This acquires total different values when it is to refer to a series of disadvantaged categories, that is the persons with locomotor disabilities. It is an inevitable social responsibility to create equal opportunities for disabled people, to prevent any intentional or unintentional discrimination that they face and apply positive discrimination if necessary to improve their living standards and to let them have an equal share from social development as productive individuals of society.
- Published
- 2014
- Full Text
- View/download PDF
27. Assessment of microalbuminuria in hypertensive patients with established coronary artery disease
- Author
-
Şalaru Delia L., Macovei Liviu, Stătescu Cristian, and Arsenescu-Georgescu Cătălina
- Subjects
microalbuminuria ,hypertension ,coronary artery disease ,microalbuminurie ,hipertensiune arterială ,boală coronariană ischemică ,Medicine - Abstract
Obiective. Evaluarea riscului cardiovascular este îmbunătăţită continuu datorită unei mai bune înţelegeri a patomecanismului aterosclerotic prin investigarea de noi factori de risc. Microalbuminuria este recunoscută ca predictor de morbiditate şi mortalitate renală, dar şi cardiovasculară la pacienţii hipertensivi. Scopul acestui studiu a fost de a determina relevanţa clinică a microalbuminuriei şi relaţia sa cu factorii de risc cardiovascular tradiţionali la pacienţii hipertensivi cu risc foarte înalt şi boală coronariană stabilită. Metode. Am colectat datele clinice şi de laborator de la 94 de pacienţi hipertensivi (aflaţi sub tratament sau nou diagnosticaţi) cu boală coronariană cunoscută (documentată angiografic) internaţi în Institutul de Boli Cardiovasculare în perioada ianuarie 2012 - aprilie 2013. Pentru diagnosticul de microalbuminurie s-a analizat o probă din prima urină de dimineaţă prin imunturbidimetrie (valori de referinţă 20-200 mg/l, grupul microalbuminuric). Pacienţii cu excreţie urinară de albumină >200 mg/l au fost excluşi. Pacienţii cu valori
- Published
- 2013
- Full Text
- View/download PDF
28. PROBLEME TERAPEUTICE LA UN PACIENT CU SPONDILITӐ ANCHILOZANTӐ ŞI STATUS POST-HEMORAGIE CEREBRALӐ.
- Author
-
Nica, Adriana Sarah, Meila, Ana-Magdalena, Macovei, L., and Brailescu, Consuela
- Published
- 2008
29. SPELEOTERAPIA.
- Author
-
Nica, Adriana Sarah, Meilă, Ana-Magdalena, and Macovei, L.
- Subjects
- *
THERAPEUTICS , *MEDICAL rehabilitation , *RESPIRATORY diseases , *SANATORIUMS , *MEDICAL care , *CLINICAL medicine , *CLINICAL trials , *MEDICAL research - Abstract
The term of speleotherapy (Gr speleo = cave) is reffering to treatment made in underground gallerys, using local caves and salt mines conditions for curring especially chronic respiratory diseases, but also deramatologic and allergic conditions. The benefits of this therapy are known from oldest times and prooved by many clinical studies. The method is less known in USA and Western Europe, but is usually used in Russia, Eastern Europe and Asia. Speleotherapy is characterized by easiness, low costs and risks. In many countries, sanatoria from salt mine benefits of special treatment conditions and large qualified staff. The purpose of this review is to attract attention on speleotherapy, a very old but efficient and still actual way of treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2007
30. FACTORI PREDICTIVI PENTRU DECES ÎN SCLERODERMIA SISTEMICĂ: UN STUDIU LONGITUDINAL.
- Author
-
Soare, Alina, Gherghe, Ana Maria, Mihai, Carina, Dobrotă, Rucsandra, Gorga, Marilena, Ionițescu, R., Jurcuț, Ruxandra, Călin, Andreea, Constantinescu, T., Sfrenț-Cornățeanu, Roxana, Macovei, L., Ancuța, I., Milicescu, Mihaela, Sasu, Mariana, Martin, A., Ginghină, Carmen, Bojincă, Mihai, and Stoica, Victor
- Subjects
- *
SYSTEMIC scleroderma , *COMORBIDITY , *AUTOIMMUNE diseases , *LONGITUDINAL method , *CAUSES of death , *PARAMETER estimation - Abstract
Background. Systemic sclerosis (SSc) is a complex autoimmune disease that involves various organs and systems and is associated with high mortality and morbidity rates. Objectives. To identify even from the first visit to the physician clinical and non-clinical parameters with predictive value for death, in patients with SSc. Methods. Demographic, clinical and non-clinical data were assessed (at each visit, according to EUSTAR recommendations) for all patients with SSc that visited our clinic between 2004-2012. Statistical analysis was done through SPSS 20.0, using chi-square and uni- and multivariate logistic regression. Results. 96 patients with SSc were included in the study, with a mean follow-up of 4.2±1.6 years. Throughout the follow-up period, there were 13 (13.5%) deaths, of whom 6 (6.2%) were of SSc cause and 7 (7.2%) of non-SSc cause. Sex- and age-adjusted univariate analysis identified the diffuse subset, a modified Rodnan score (mRSS) >14, digital ulcers, restrictive ventilatory syndrome, proteinuria, heart rhythm and conduction anomalies and hypo/ hyperpygmentation of the skin to be associated with increased mortality in all patients. Sex- and age-adjusted multivariate model identified a mRSS >14 and proteinuria as predictors of death. With regard to deaths that can be attributed to SSc, univariate analysis identified a mRSS >14, digital ulcers and proteinuria as predictive factors. Conclusions. The survival rate of patients included in the study was over 86% during a mean follow-up period of 5 years. Several clinical and non-clinical parameters which can be deemed predictive factors for death in patients with SSc were identified. Moreover, these can be detected early, from the patient's first visit to the physician, and can have an important role in developing a management strategy for the patient with SSc. [ABSTRACT FROM AUTHOR]
- Published
- 2013
31. The Prognostic Value of Creatine Kinase-MB Dynamics after Primary Angioplasty in ST-Elevation Myocardial Infarctions.
- Author
-
Popa DM, Macovei L, Moscalu M, Sascău RA, and Stătescu C
- Abstract
Background: In STEMIs, the evaluation of the relationship between biomarkers of myocardial injury and patients' prognoses has not been completely explored. Increased levels of CK-MB in patients with a STEMI undergoing primary angioplasty are known to be associated with higher mortality rates, yet the correlation of these values with short-term evolution remains unknown., Material and Methods: The research encompassed a sample of 80 patients diagnosed with STEMIs, and its methodology entailed a retrospective analysis of the data collected during their hospital stays. The study population was then categorized into three distinct analysis groups based on the occurrence or absence of acute complications and fatalities., Results: The findings indicated that there is a notable correlation between rising levels of CK-MB upon admission and peak CK-MB levels with a reduction in left ventricular ejection fraction. Moreover, the CK-MB variation established a point of reference for anticipating complications at 388 U/L, and a cut-off value for predicting death at 354 U/L., Conclusion: CK-MB values are reliable indicators of the progress of patients with STEMIs. Furthermore, the difference between the peak and admission CK-MB levels demonstrates a high accuracy of predicting complications and has a significant predictive power to estimate mortality risk.
- Published
- 2023
- Full Text
- View/download PDF
32. Coronary Syndromes and High-Altitude Exposure-A Comprehensive Review.
- Author
-
Macovei L, Macovei CM, and Macovei DC
- Abstract
The aim of this review is to identify a preventive strategy in order to minimize the risk of adverse events in patients with coronary syndromes and acute exposure to high-altitude. For this purpose we searched the electronic database of PubMed, EMBASE, and Web of Science for studies published in the last 30 years in this field. The conclusions of this review are: patients with stable coronary artery disease on optimal treatment and in a good physical condition can tolerate traveling to high altitude up to 3500 m; on the other hand, patients with unstable angina or recent myocardial infarction no older than 6 months should take less interest in hiking or any activity involving high altitude. Air-traveling is contraindicated for patients with myocardial infarction within previous 2 weeks, angioplasty or intracoronary stent placement within previous 2 weeks, and unstable angina or coronary artery bypass grafting within previous 3 weeks. The main trigger for sudden cardiac death is the lack of gradual acclimatization to high-altitude and to the exercise activity, and the most important risk factor is prior myocardial infarction.
- Published
- 2023
- Full Text
- View/download PDF
33. Quality of Life of Older Persons: The Role and Challenges of Social Services Providers.
- Author
-
Ghenţa M, Matei A, Mladen-Macovei L, and Stănescu S
- Subjects
- Aged, Aged, 80 and over, Focus Groups, Humans, Social Work, Home Care Services, Quality of Life psychology
- Abstract
Considering the growing number of older persons, ensuring the quality of life of them, as well as the social services designed for this population category, has become more and more important. Especially in the case of dependent older persons, social services are essential components, as they contribute to a better quality of life. The aim of this paper was to examine the perspectives of social services providers for older persons with respect to their role and the challenges encountered in ensuring the quality of life of older beneficiaries. In order to answer our objectives, we employed a qualitative methodology, using the focus group method to collect information from social services providers (both residential and home care). Multiple factors are related to a good quality of life in old age: some are related to individual characteristics, while others are related to the provision of services. The provision of quality social services that adequately respond to the needs of beneficiaries contributes to increasing the degree of independence and maintaining the physical and mental health of dependent older persons.
- Published
- 2022
- Full Text
- View/download PDF
34. Factors Associated with the Participation of Older Adults in Cultural and Sports Activities.
- Author
-
Ghența M, Matei A, Mladen-Macovei L, and Bobârnat ES
- Subjects
- Aged, Aged, 80 and over, Aging, Humans, Income, Surveys and Questionnaires, Sports
- Abstract
In the context of population aging, we have witnessed an increased interest in studying the participation of older persons in cultural and sport activities. The aim of this paper is to identify the participation rate in cultural and sports activities among Romanian older adults and the sociodemographics/behavioral variables that correlate with the participation rate in cultural and sports activities. In order to answer our research questions, we employed a questionnaire-based survey, and we used a nationally representative sample. Results point to low participation in both cultural and sports activities. Gender, residence, education, income, degree of mobility, internet connection, and availability of financial resources are significant variables that correlate with the engagement of older people in cultural and sports activities. Our study could serve as a base for concrete policy measures in the field of health and social inclusion of older persons.
- Published
- 2022
- Full Text
- View/download PDF
35. Beta-Blocker-Related Atrioventricular Conduction Disorders-A Single Tertiary Referral Center Experience.
- Author
-
Marcu DTM, Adam CA, Dorobanțu DM, Șalaru DL, Sascău RA, Balasanian MO, Macovei L, Arsenescu-Georgescu C, and Stătescu C
- Subjects
- Aged, Aged, 80 and over, Electrocardiography, Female, Humans, Male, Retrospective Studies, Stroke Volume, Tertiary Care Centers, Sick Sinus Syndrome complications, Sick Sinus Syndrome therapy, Ventricular Function, Left
- Abstract
Background and Objectives : Drug-related bradyarrhythmia is a well-documented major adverse event among beta-blocker users and a potential cause for hospitalization or additional interventions. Whether beta-blocker use is associated with specific bradyarrhythmia presentations, and how this relates to other predisposing factors, is not well known. We aim to evaluate the association between beta-blocker use and the type of atrioventricular (AV) conduction disorder in patients with symptomatic bradycardia. Materials and Methods : We conducted a retrospective cohort study on 596 patients with a primary diagnosis of symptomatic bradyarrhythmia admitted to a single tertiary referral center. Of the cases analyzed, 253 patients were on beta-blocker treatment at presentation and 343 had no bradycardic treatment. We analyzed demographics, clinical and paraclinical parameters in relation to the identified AV conduction disorder. A multivariate regression analysis was performed to explore factors associated with beta-blocker use. Results : Of the 596 patients (mean age 73.9 ± 8.8 years, 49.2% male), 261 (43.8%) had a third-degree AV block, 92 (15.4%) had a second-degree AV block, 128 (21.5%) had slow atrial fibrillation, 93 (15.6%) had sick sinus syndrome and 21 (3.5%) had sinus bradycardia/sinus pauses. Beta-blocker use was associated with the female gender ( p < 0.001), emergency admission ( p < 0.001), dilated cardiomyopathy ( p = 0.003), the lower left ventricular ejection fraction ( p = 0.02), mitral stenosis ( p = 0.009), chronic kidney disease ( p = 0.02), higher potassium levels ( p = 0.04) and QRS duration > 120 ms ( p = 0.02). Slow atrial fibrillation (OR = 4.2, p < 0.001), sick sinus syndrome (OR = 2.8, p = 0.001) and sinus bradycardia/pauses (OR = 32.9, p < 0.001) were more likely to be associated with beta-blocker use compared to the most common presentation (third-degree AV block), after adjusting for other patient characteristics. Conclusions : Beta-blocker use is more likely to be associated with slow atrial fibrillation, sick sinus syndrome and sinus bradycardia/pauses, compared to a second- or third-degree AV block, after adjusting for other patient factors such as gender, admission type, ECG, comorbidities, cardiac function and lab testing.
- Published
- 2022
- Full Text
- View/download PDF
36. Risk factors associated with intra-stent restenosis after percutaneous coronary intervention.
- Author
-
Alexandrescu DM, Mitu O, Costache II, Macovei L, Mitu I, Alexandrescu A, and Georgescu CA
- Abstract
The present study aimed to explore the correlations between clinical, biological, imagistic and procedural factors with the risk of intra-stent restenosis (ISR) in coronary artery disease (CAD) patients after percutaneous coronary intervention (PCI). An observational cross-sectional study was conducted in a high-volume PCI center over a period of 2 years. A total of 235 consecutive patients diagnosed with angina or acute coronary syndrome treated by PCI were included in the study. Diagnosis of ISR was documented by coronary angiography in patients with suggestive coronary symptoms and ischemic changes in non-invasive or invasive paraclinical investigations. Thus, they were assigned to two groups: With or without ISR. All patients underwent clinical and laboratory examination, providing clinical and paraclinical variables that could be considered risk factors for ISR. Current smokers [risk ratio (RR)=1.63; 95% confidence interval (95% CI): 1.25-2.13], arterial hypertension (RR=1.86; 95% CI: 1.41-2.45), diabetes (RR=1.83; 95% CI: 1.42-2.36), high C-reactive protein (CRP) levels (RR=1.44; 95% CI: 0.93-2.24), chronic kidney disease (CKD) (RR=1.90; 95% CI: 1.53-2.36) and thrombolysis in myocardial infarction (TIMI) score were found to have a significant role in estimating the risk for ISR. Moreover, the ISR group (119 patients) presented with a lower stent inflation pressure when compared to the control group (116 patients) (14.47 vs. 16.14 mmHg, P=0.004). An increased mean stent diameter used for PCI was not associated with a high ISR incidence (P=0.810) as well as complex coronary treated lesions with longer stents (mean length of 24.98 mm in patients without ISR vs. 25.22 mm in patients with ISR; P=0.311). There was an estimated two times higher risk (RR=2.13; 95% CI: 1.17-3.88) concerning multi-stenting and restenosis degree >70%. To conclude, smoking, hypertension, diabetes mellitus, high CRP levels, CKD, TIMI score, stent type, low pressure for stent implantation and multi-stenting were found to be associated with ISR in patients following PCI. Therefore, a close follow-up should be targeted in such patients., Competing Interests: The authors declare that they have no competing interests., (Copyright: © Alexandrescu et al.)
- Published
- 2021
- Full Text
- View/download PDF
37. Acute myocardial infarction and extensive systemic thrombosis in thrombotic thrombocytopenic purpura: A case report and review of literature.
- Author
-
Șalaru DL, Adam CA, Marcu DTM, Șimon IV, Macovei L, Ambrosie L, Chirita E, Sascau RA, and Statescu C
- Abstract
Background: Thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy characterized by the pentad of hemolytic anemia, fever, thrombocytopenia, renal failure, and neurological dysfunction. The formation of microthrombi in the arterioles and capillaries of various organs is one of the main pathophysiological mechanisms. Clinical manifestations of cardiac involvement in TTP patients are variable. Acute myocardial infarction has been reported as a complication with TTP as the secondary thrombotic event. Its emergence as the initial thrombotic event is extremely rare., Case Summary: A 49-year-old previously healthy man was admitted for fever, typical angina chest pain 3 d prior to presentation, and newly onset left lower limb pain. The electrocardiogram illustrated ST-elevation acute myocardial infarction of the antero-lateral wall of the left ventricle. Transthoracic echocardiography depicted two large thrombi at the apex of the left ventricle and moderately reduced ejection fraction (40%). Venous Doppler ultrasound showed occlusion of the left popliteal artery. Laboratory tests showed severe thrombocytopenia, mild hemolytic anemia, elevated D-dimers, and high troponin and creatine kinase-MB. Abdominal computed tomography revealed other thrombotic sites (superior mesenteric artery, posterior aortic wall, spleen and renal infarction, and ileum necrosis). He was immediately started on steroids and addressed to surgery for acute abdominal pain. After an initial stabilization of the hematological deficit, he went into general surgery for resection of the necrotic ileum but died soon after the intervention due to multiple organ failure., Conclusion: Cardiac involvement in TTP patients is common, challenging and more often fatal, especially when other thrombotic complications coexist., Competing Interests: Conflict-of-interest statement: The authors declare that they have no conflict of interest., (©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
38. A Systematic Review on the Correlations between Left Atrial Strain and Cardiovascular Outcomes in Chronic Kidney Disease Patients.
- Author
-
Tanasa A, Burlacu A, Popa C, Kanbay M, Brinza C, Macovei L, Crisan-Dabija R, and Covic A
- Abstract
Left atrial strain (LASr) represents a relatively new but promising technique for left atrial and left ventricle function evaluation. LASr was strongly linked to myocardial fibrosis and endocardial thickness, suggesting the utility of LASr in subclinical cardiac dysfunction detection. As CKD negatively impacts cardiovascular risk and mortality, underlying structural and functional abnormalities of cardiac remodeling are widely investigated. LASr could be used in LV diastolic dysfunction grading with an excellent discriminatory power. Our objectives were to assess the impact and existing correlations between LASr and cardiovascular outcomes, as reported in clinical trials, including patients with CKD. We searched PubMed, Web of Science, Embase, and the Cochrane Central Register of Controlled Trials for full-text papers. As reported in clinical studies, LASr was associated with adverse cardiovascular outcomes, including cardiovascular death and major adverse cardiovascular events (HR 0.89, 95% CI, 0.84-0.93, p < 0.01), paroxysmal atrial fibrillation (OR 0.847, 95% CI, 0.760-0.944, p = 0.003), reduced exercise capacity (AUC 0.83, 95% CI, 0.78-0.88, p < 0.01), diastolic dysfunction ( p < 0.05), and estimated pulmonary capillary wedge pressure ( p < 0.001). Despite limitations attributed to LA deformation imaging (image quality, inter-observer variability, software necessity, learning curve), LASr constitutes a promising marker for cardiovascular events prediction and risk evaluation in patients with CKD.
- Published
- 2021
- Full Text
- View/download PDF
39. Drug-eluting stents: new presumed effects over in-stent restenosis prevention.
- Author
-
Macovei L, Magopet R, and Campo G
- Subjects
- Humans, Reperfusion, Stents, Coronary Restenosis prevention & control, Drug-Eluting Stents, ST Elevation Myocardial Infarction
- Published
- 2021
- Full Text
- View/download PDF
40. A Systematic Review on Bleeding Risk Scores' Accuracy after Percutaneous Coronary Interventions in Acute and Elective Settings.
- Author
-
Brinza C, Burlacu A, Tinica G, Covic A, and Macovei L
- Abstract
Dual antiplatelet therapy (DAT) is recommended for all patients undergoing percutaneous coronary intervention (PCI), as it significantly reduces the ischemic risk at the cost of increasing the incidence of bleeding events. Several clinical predictive models were developed to better stratify the bleeding risk associated with DAT. This systematic review aims to perform a literature survey of both standard and emerging bleeding risk scores and report their performance on predicting hemorrhagic events, especially in the era of second-generation drug-eluting stents and more potent P2Y12 inhibitors. We searched PubMed, ScienceDirect, and Cochrane databases for full-text studies that developed or validated bleeding risk scores in adult patients undergoing PCI with subsequent DAT. The risk of bias for each study was assessed using the prediction model risk of bias assessment tool (PROBAST). Eighteen studies were included in the present systematic review. Bleeding risk scores showed a modest to good discriminatory power with c-statistic ranging from 0.49 (95% CI, 0.45-0.53) to 0.82 (95% CI, 0.80-0.85). Clinical models that predict in-hospital bleeding events had a relatively good predictive performance, with c-statistic ranging from 0.70 (95% CI, 0.67-0.72) to 0.80 (95% CI, 0.73-0.87), depending on the risk scores and major hemorrhagic event definition used. The knowledge and utilization of the current bleeding risk scores in appropriate clinical contexts could improve the prediction of bleeding events.
- Published
- 2021
- Full Text
- View/download PDF
41. Capillary loss reflects disease activity and prognosis in patients with systemic sclerosis.
- Author
-
Gheorghiu AM, Oneata R, Ancuta I, Enuica A, Linte O, Macovei L, Bojinca M, Stoica V, and Mihai C
- Abstract
Capillary density on nailfold capillaroscopy (NFC) is considered a promising instrument for assessing disease characteristics in patients with systemic sclerosis (SSc), however, there is no agreement yet over how to analyze and interpret the results. The objective of this study was to investigate the possible associations of the mean number of capillaries with disease characteristics, disease activity [measured by the European Scleroderma Study Group (EScSG) disease activity score] and survival in a single-center cohort of patients with SSc. Sixty-eight patients were included; 54 had follow-up at 6 months. Thirty-two images per patient were assessed independently by two raters, scoring the mean number of capillaries in all fingers (N), in the 3rd finger of the dominant hand (dN
3 ) and in the 4th finger of the non-dominant hand (ndN4 ) for each patient. NFC 'early', 'active' and 'late' patterns were also assessed. Two thousand and seventy-six images were scored at baseline, 1,728 at follow-up. Baseline N was median (IQR) 5.1 (2.7) for rater 1, and 4.9 (1.7) for rater 2, respectively. N was significantly lower in patients with a history of digital ulcers (DUs), vs. those who never had DUs 4.8 (1.4) vs. 6.4 (3.1), P=0.016. A lower N was associated with higher disease activity at baseline and follow-up (linear regression adjusted for age, sex and history of DUs). A lower ndN4 was associated with increased mortality (logistic regression adjusted for age and sex). In conclusion, in patients with SSc, a lower mean number of capillaries assessed by NFC was associated with higher disease activity after 6 months of follow-up and with shorter survival., (Copyright © 2020, Spandidos Publications.)- Published
- 2020
- Full Text
- View/download PDF
42. Coronary artery bypass graft surgery versus percutaneous coronary intervention in unprotected left main coronary artery disease: A systematic review.
- Author
-
Macovei L, Magopet R, Tanasa A, Raileanu C, Prisacariu C, Presura MR, and Balasanian MO
- Subjects
- Clinical Decision-Making, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease mortality, Evidence-Based Medicine, Humans, Patient Selection, Risk Assessment, Risk Factors, Treatment Outcome, Coronary Artery Bypass adverse effects, Coronary Artery Bypass mortality, Coronary Artery Disease therapy, Percutaneous Coronary Intervention adverse effects, Percutaneous Coronary Intervention mortality
- Abstract
Critical lesion of the unprotected left main coronary disease carries a tremendous mortality burden, often associated with a diabetes status or multivessel disease, with coronary artery bypass grafting being the standard treatment for over 40 years. Percutaneous coronary intervention with drug eluting stents should be taken into consideration and could be a better option for patients with low SYNTAX score as validated by the recently published studies. This review summarizes the major randomized clinical trials and meta-analyses concerning the debate regarding percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting for unprotected left main coronary disease, along with the latest European and American revascularization guidelines and tries to shed light on this matter. The most results advocate that there is no convincing difference in survival rate for both therapies, especially in patients with isolated left main disease but with fewer major ischemic events for coronary artery bypass grafting when compared with percutaneous coronary intervention in multivessel coronary artery disease, at the rate of a higher stroke incidence. The gaps in evidence are also highlighted, especially the lack of randomized clinical trials with new generation drug eluting stents versus coronary artery bypass grafting or those regarding the best revascularization strategy for an acute coronary syndrome when unprotected left main coronary disease is involved., Competing Interests: The authors declare no conflicts of interest statement., (© 2020 Macovei et al. Published by IMR press.)
- Published
- 2020
- Full Text
- View/download PDF
43. Local Thrombolysis in High-Risk Pulmonary Embolism-13 Years Single-Center Experience.
- Author
-
Macovei L, Presura RM, Magopet R, Prisecariu C, Macovei C, Omete G, Nedelciuc I, and Balasanian M
- Subjects
- Female, Humans, Male, Middle Aged, Time Factors, Pulmonary Embolism complications, Thrombolytic Therapy methods
- Abstract
To evaluate the prognosis after local thrombolysis compared to systemic thrombolysis in high-risk pulmonary embolism. Observational study during 13 years which included 37 patients with high-risk pulmonary embolism treated with local thrombolysis and 36 patients with systemic thrombolysis (streptokinase, 250 000 UI/30 minutes followed by 100 000 UI/h). Cardiogenic shock has totally remitted in the group with local thrombolysis ( P = .002). The decrease in pressure gradient between right ventricle and right atrium was comparable in both groups in the acute period (the results being influenced by the higher in-hospital mortality after systemic thrombolysis), but significantly better in the next 24 months follow-up after in situ thrombolysis. Major and minor bleeding did not have significant differences. In hospital, mortality was significantly lower in the group with local thrombolysis ( P = .003), but for the next 24 months follow-up, the survival was comparable in both groups. Local thrombolysis, during the hospitalization, was associated with lower mortality rate comparing with systemic thrombolysis. In the next 24 months follow-up, the evolution of residual pulmonary hypertension was significantly better after in situ thrombolysis.
- Published
- 2020
- Full Text
- View/download PDF
44. Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol.
- Author
-
Soare A, Gheorghiu AM, Aramă V, Bumbăcea D, Dobrotă R, Oneaţă R, Pintilie S, Milicescu M, Ancuţa I, Martin A, Sasu M, Ciofu C, Macovei L, Stoica V, Bojincă M, and Mihai C
- Subjects
- Adalimumab administration & dosage, Adalimumab adverse effects, Antibodies, Monoclonal administration & dosage, Antibodies, Monoclonal adverse effects, Antirheumatic Agents administration & dosage, Arthritis, Psoriatic drug therapy, Certolizumab Pegol administration & dosage, Certolizumab Pegol adverse effects, Etanercept administration & dosage, Etanercept adverse effects, Female, Humans, Infliximab administration & dosage, Infliximab adverse effects, Latent Tuberculosis diagnosis, Male, Middle Aged, Retrospective Studies, Risk, Spondylitis, Ankylosing drug therapy, Tuberculin Test, Tuberculosis diagnosis, Tuberculosis prevention & control, Antirheumatic Agents adverse effects, Arthritis, Rheumatoid drug therapy, Tuberculosis chemically induced, Tumor Necrosis Factor-alpha antagonists & inhibitors
- Abstract
Tuberculosis (TB) is a major concern in patients receiving TNF inhibitors (TNFi). This study aimed to assess the incidence of active TB and the efficacy of TB prevention measures used over the years, and to determine risk factors for developing TB, in a single-centre cohort of patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) receiving TNFi. Data of all patients in whom treatment with TNFi was initiated in our rheumatology clinic until December 1st 2014 have been retrospectively analysed. The cohort was divided into 3 groups per the mandatory LTBI screening method at baseline: tuberculin skin test (TST) with a positive threshold of either 10 mm (group TST1), or 5 mm (group TST2), and QuantiFERON®-TB Gold test (group QFT). The incidence of active TB was analysed for each group and compared to TB incidence data in general population. Five hundred fifty patients were included (305 RA, 42 PsA, 203 AS); 97 patients belonged to the TST1, 229 to the TST2 and 224 to the QFT group. The number of active TB cases/time of exposure to TNFi (person-years, PY) was 8/593.5, 9/1044.0 and 3/555.3, respectively, accounting for an incidence of 1348.0, 862.1 and 540.2 cases per 10
5 PY. Active TB cases occurring in the first year of TNFi treatment (early TB) per total TB cases were only 3/8, 1/9 and 1/3, respectively, too few to identify statistically significant differences between the 3 LTBI screening protocols. However, less TB cases per total observation time were registered in the QFT group, probably due to the reduced duration of exposure to TNFi. All cases of active TB were registered among patients receiving monoclonal antibodies TNFi agents. We have found no significant risk factors for developing active TB. In our cohort, TB occurring after 1 year of TNFi treatment exceeds 'early TB', suggesting the necessity of further TB prevention measures besides baseline screening for LTBI.- Published
- 2018
- Full Text
- View/download PDF
45. Endothelial keratoplasty for Fuchs dystrophy.
- Author
-
Macovei L and Gobej I
- Subjects
- Aged, Endothelium, Corneal, Female, Humans, Visual Acuity, Cornea surgery, Descemet Stripping Endothelial Keratoplasty, Fuchs' Endothelial Dystrophy surgery
- Abstract
We report the case of a 69-year-old female with Fuchs endothelial dystrophy and posterior chamber in-the-bag intraocular lens, whom we treated with DMEK surgical technique. We encountered difficulties both during obtaining the endothelium from the young donor and during the intraocular unrolling and its application on the stroma. We evaluated both preoperative and postoperative the following parameters: visual acuity, slit lamp, and optical coherence tomography appearance of the cornea, corneal thickness, intraocular pressure, endothelial cell density. In all postoperative assessments, the endothelium was attached to the host's stroma, with small peripheral, inferior folding area. Short-term results were favorable with a clear cornea and significant improvement in visual acuity obtained in the first 3 months of postoperative follow-up. Abbreviation : BCVA = best-corrected visual acuity, RE = right eye, LE = left eye, OCT = optical coherence tomography, DMEK = Descemet membrane endothelial keratoplasty.
- Published
- 2017
46. The Link Between Quality of Life and Economic Issues in Ankylosing Spondylitis.
- Author
-
Rezus E, Cardoneanu A, Macovei L, Stamate G, and Burlui A
- Subjects
- Activities of Daily Living, Cost of Illness, Evidence-Based Medicine, Humans, Pain etiology, Romania, Severity of Illness Index, Spondylitis, Ankylosing complications, Spondylitis, Ankylosing economics, Quality of Life, Spondylitis, Ankylosing diagnosis, Spondylitis, Ankylosing physiopathology
- Abstract
Ankylosing spondylitis (AS) is an inflammatory rheumatic disorder which mainly involves the axial skeleton. The most important clinical features are: inflammatory back pain and peripheral joint involvement, but extra-articular manifestations that occur most often in the eyes, heart and lungs may also be present. Joint stiffness, pain and a progressive loss of spinal mobility can lead to severe functional limitations with subsequent negative impact on patients' quality of life. These symptoms can interfere not only with physical health, but also with social life and psychological wellbeing. Many studies took into consideration these aspects and tried to analyze the relationship between disease activity, functional impairment, work ability, interpersonal relationships and total costs of this debilitating disease. After many years of studying, the authors concluded that AS has a socio-economic impact on patients, society and healthcare system.
- Published
- 2016
47. The hidden 'mycobacteriome' of the human healthy oral cavity and upper respiratory tract.
- Author
-
Macovei L, McCafferty J, Chen T, Teles F, Hasturk H, Paster BJ, and Campos-Neto A
- Abstract
The incidence of opportunistic non-tuberculous mycobacteria (NTM) infections has increased considerably in the past decades causing an array of infections, including respiratory and soft-tissue infections. NTM are ubiquitous and can be found in numerous environments, including households and water plants. However, NTM have not been reported to be associated with the healthy human oral microbiome. Since the oral cavity and upper respiratory track are the main ports of entry of microorganisms into the human body, elucidating NTM diversity and prevalence will assist in the assessment of the potential risks of infection elicited by these opportunistic pathogens. Here, we report the identification of a 'non-tuberculous mycobacteriome' in healthy individuals. We employed a modified DNA extraction procedure in conjunction with mycobacterial-specific primers to screen niches in the oral cavity (buccal mucosa and dental plaque) and upper respiratory tract (nostrils and oropharynx) of 10 healthy subjects. A total of 50 prevalent operational taxonomic units sequenced on MiSeq (Illumina) using 16S rRNA V3-V4 region were detected across all screened niches, showing the presence of diverse NTM communities. NTM DNA was detected in the nostrils of all 10 subjects, in buccal mucosa of 8 subjects, in the oropharynx of 7 subjects, and in the dental plaques of 5 subjects. Results from quantitative PCR showed each individual harbored 10(3)-10(4) predicted NTM per each screened niche. The modification of standard DNA isolation methods to increase sensitivity toward mycobacterial species represents an important step to advance the knowledge of the oral as well as the overall human microbiome. These findings clearly reveal for the first time that healthy individuals harbor a 'non-tuberculous mycobacteriome' in their oral cavity and upper respiratory tract and may have important implications in our understanding of infections caused by NTM.
- Published
- 2015
- Full Text
- View/download PDF
48. Systemic or local thrombolysis in high-risk pulmonary embolism.
- Author
-
Macovei L, Presura RM, and Arsenescu Georgescu C
- Subjects
- Adult, Aged, Echocardiography, Electrocardiography, Female, Fibrinolytic Agents adverse effects, Hemodynamics drug effects, Hemorrhage chemically induced, Humans, Infusions, Intra-Arterial, Infusions, Intravenous, Male, Middle Aged, Pulmonary Artery, Pulmonary Embolism diagnosis, Pulmonary Embolism mortality, Pulmonary Embolism physiopathology, Risk Factors, Romania, Streptokinase adverse effects, Thrombolytic Therapy adverse effects, Thrombolytic Therapy mortality, Time Factors, Treatment Outcome, Fibrinolytic Agents administration & dosage, Pulmonary Embolism drug therapy, Streptokinase administration & dosage, Thrombolytic Therapy methods
- Abstract
Background and Aim: High-risk pulmonary embolism (PE) represents an important health problem in emergency cardiology, being associated with a high rate of mortality. The aim of this study is to assess the efficacy and safety of pulmonary intra-arterial thrombolysis with streptokinase compared to systemic thrombolysis., Methods and Results: In our study, 28 patients with acute high risk PE were treated by intra-arterial thrombolysis with clinical success rate of 96.4%, while in the group with systemic thrombolysis (24 patients) the rate of clinical success was significantly lower (70.8%). Also, pressure gradient between right ventricle (RV) and right atrial (RA) (PRV-RA) decreased significantly in patients treated by pulmonary intra-arterial thrombolysis instead of systemic thrombolysis. Mortality during the hospitalization was 0% in the group with local thrombolysis and 29.2% in the other group, with a significant statistical difference. Major bleeding complications appeared in 14.3% of the patients with local thrombolysis and in 20.8% of the ones treated by systemic thrombolysis, without statistical significance. Moreover, the proportion of minor bleeding was comparable in the two groups of patients. There was no intracranial bleeding. Disseminated intravascular coagulation occurred in 1 patient with systemic thrombolysis., Conclusions: The rate of clinical success and the regression of RV overload were significantly higher in patients treated by pulmonary intra-arterial thrombolysis. The results regarding the efficiency of the pulmonary intra-arterial thrombolysis in high-risk PE are encouraging, the mortality in these patients being significantly lower than the one for systemic administration of the thrombolytic agent.
- Published
- 2015
- Full Text
- View/download PDF
49. Acute gout attack with normal serum uric acid levels.
- Author
-
Bădulescu M, Macovei L, and Rezuş E
- Subjects
- Acute Disease, Adult, Aged, Aged, 80 and over, Biomarkers blood, Biomarkers urine, Blood Sedimentation, Female, Gout blood, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Sensitivity and Specificity, Uric Acid blood, C-Reactive Protein metabolism, Colchicine, Gout diagnosis, Gout Suppressants, Uric Acid urine
- Abstract
Aim: The paper aims to determine the prevalence of clinical cases with acute gout attacks and normal serum uric acid levels., Material and Methods: This retrospective study was conducted between October, 2013 and June, 2014 in 30 patients diagnosed with acute gout attack admitted to the 1st Clinic of Rheumatology of Iasi. The diagnosis was based on clinical manifestations and positive response to therapeutic test with colchicine., Results: Normal serum uric acid levels were found in 63.3% of the patients with acute gout attack. The inflammatory syndrome was detected in 76.6% of patients with high erythrocyte sedimentation rate (ESR) levels and in 30% of patients who had elevated C-reactive protein levels. The urinary excretion of uric acid was measured in 11 patients and it was found increased in 55% of them., Conclusions: The diagnosis of acute gout attack should not be excluded in the presence of normal serum uric acid levels if the clinical manifestations or the positive response at colchicine are suggestive of gout. The low uric acid level is correlated with increased inflammatory factors and urinary excretion of uric acid.
- Published
- 2014
50. Differentiation of rheumatoid arthritis from hepatitis C-related arthropathy: case report.
- Author
-
Dima-Cozma C, Mitu F, Macovei L, Arhire O, and Rezuş E
- Subjects
- Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Antirheumatic Agents therapeutic use, Arthritis, Infectious virology, Arthritis, Rheumatoid complications, Arthritis, Rheumatoid diagnosis, Arthritis, Rheumatoid drug therapy, Biomarkers blood, Body Mass Index, Diagnosis, Differential, Drug Therapy, Combination, Female, Humans, Hydroxychloroquine therapeutic use, Peptides, Cyclic blood, Predictive Value of Tests, Risk Factors, Sensitivity and Specificity, Treatment Outcome, Antibodies, Anti-Idiotypic blood, Arthritis, Infectious immunology, Arthritis, Rheumatoid immunology, Hepatitis C, Chronic complications, Immunologic Factors blood, Rheumatoid Factor blood
- Abstract
Chronic virus C hepatitis records high prevalence, almost 170 million people worldwide being infected. Systemic involvement is frequent and the implication of the osteoarticular system raises various problems in properly diagnosing and treating it. Rheumatoid arthritis is the most frequent type of inflammatory polyarthritis, with a prevalence of 0.8% in the general population. The rheumatoid factor recorded high values at virus C hepatitis patients (19-80%) even in the absence of articular manifestations, its sensitivity and specificity being reduced for the rheumatoid arthritis diagnosed simultaneous with virus C hepatitis. We report a case of chronic virus C hepatitis patient which, after 30 years of evolution, presents the onset of senile rheumatoid polyarthritis. The authors discuss the usefulness dosage of anti-cyclic citrullinated peptide antibodies for establishing the differential diagnosis between rheumatoid arthritis and hepatitis C-related arthropathy and the particularities of the specific treatment when there is a hepatitis C virus associated infection.
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.